The FMP1/AS02A malaria vaccine, which is currently being tested in the field [28–30], is based on the C-terminal 42 kDa of MSP-1 from the 3D7 strain of P. falciparum [31] and contains amino acids ETSSRL at the six polymorphic residues in MSP-119. This evidence concerns the gene ATAD1 and malaria.